Drug firm Alembic Pharmaceuticals on Friday reported a 81.15 per cent rise in its consolidatednet profit to Rs 224.63 crore for March quarter mainly on account of robust sales.
The company had posted a net profit of Rs 124 crore for the corresponding period of previous fiscal, Alembic Pharmaceuticals said in a filing to the BSE.
Consolidatedrevenue from operations of the company stood at Rs 1,206.83 crore for the quarter under considerationas against Rs 926.95 crore for the same period year ago, it added.
For the fiscal year 2019-20, the company posted a net profit of Rs828.82 crore as against Rs 584.37 crore for 2018-19,Alembic Pharmaceuticals said.
The consolidated revenue from operations for the fiscal ended March 2020 stood at Rs 4,605.75 crore. It was Rs 3,934.68 crore for FY19, it added.
Shares of Alembic Pharmaceuticals closed at Rs897.50per scrip on the BSE, down 0.02 per cent over previous close.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)